New Customer?
Continue- Track your orders
- Save your details for express checkout
Orders Update
Please be advised that there is a slight delay on orders being dispatched. We are committed to getting these orders out to you as swiftly as possible and appreciate your patience and understanding during this period.
Roche SARS-CoV-2 Rapid Antigen Test Nasal - 5 Self Tests
The SARS-CoV-2 Antigen Self Test Nasal provides reliable results for individuals suspected of having COVID-19 within 15 minutes.
Testing whenever and wherever needed can be the basis for safer decision making and a step towards more normality for everyone.
The benefits of the Rapid Antigen Test:
Kindly note that we are unable to accept returns on all Rapid Antigen Test Kits.
An aid in identifying individuals infected by SARS-CoV-2
The SARSCoV2 Antigen Self Test Nasal is a lateral flow test for the qualitative detection of SARSCoV2 nucleocapsid antigen in human nasal samples. This test is used to detect antigens of the SARSCoV2 virus in individuals suspected of having COVID19 and is designed as a selftest for the general public.
The benefit of having a SARS-CoV-2 antigen test available
The SARS-CoV-2 virus causes respiratory tract infection. It is transmitted mainly via respiratory droplets after close contact, and primary viral replication is presumed to occur in mucosal epithelium of the upper respiratory tract (nasal cavity and pharynx).2 At these locations viral load peaks within the first week after symptom onset, and then declines.
A SARS-CoV-2 antigen test detects the presence of the SARS-CoV-2 virus from part of the upper respiratory tract swab specimens by identifying a nucleoprotein that is carried by the virus. The test identifies current infection during the acute phase of COVID-19, while the virus is still present in large quantities in the respiratory tract.
Roche Diagnostics believe wide accessibility to such high-performance, instrument-free and reliable Point of Care tests can contribute significantly to better managing the ongoing pandemic crisis.
Key Benefits
Testing is possible everywhere: Decentralized testing minimizes the possibility of exposure of healthcare workers to potentially infected individuals while protecting healthcare capacity.
A tool to safely re-open the economy: Tested individuals might be able to travel and participate in events, while reducing the risk of spreading the virus.
Real-world evidence: Independent performance studies with large sample sizes, including professional collection, self-collection and self-testing groups.
Reliable answers: High test quality and performance.
Quick results: Faster results compared to laboratory testing.
Easy repetitive testing: No need to visit a healthcare professional or schedule an appointment.
Easy handling procedure: Reduced handling errors and waste.
Increased user protection: Virus inactivation by extraction buffer after 2 minutes.
Peace of mind: Worrying symptoms can be put into perspective.